Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Urinary coenzyme Q10 as a diagnostic biomarker and predictor of remission in a patient with ADCK4-associated Glomerulopathy: a case report.

BMC nephrology - 7 Jan 2021

Zhang Yan, Liao Xiaohua, Jiang Yupeng, Lv Xin, Yu Yue, Dai Qin, Ao Liyun, Tao Lijian, Peng Zhangzhe

Abstract excerpt

BACKGROUND: AarF domain-containing kinase 4 (ADCK4)-associated glomerulopathy is a mitochondrial nephropathy caused by mutations in the ADCK4 gene, which disrupt coenzyme Q10 biosynthesis. CASE PRESENTATION: We report the case of a 25-year-old female patient with ADCK4-associated glomerulopathy presenting with proteinuria (and with no additional systemic symptoms). A known missense substitution c.737G > A...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Kidney Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kidney Glomerulus

Share to Mutation

Share to Predictive Value of Tests

Share to Prognosis

Share to Protein Kinases

Share to Ubiquinone

Source

Open in PubMed Open full text

Identifiers

PMID: 33413146
DOI: 10.1186/s12882-020-02208-7
PMCID: PMC7791994

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Urinary coenzyme Q10 as a diagnostic biomarker and predictor of remission in a patient with ADCK4-associated Glomerulopathy: a case report.PMID 33413146Read ↗

Coenzyme Q10 supplementation therapy for 2 children with proteinuria renal disease and ADCK4 mutation: Case reports and literature review.Semantic proximity Read ↗

Early-onset of ADCK4 glomerulopathy with renal failure: a case report.Semantic proximity Read ↗

Long-term follow-up results of patients with ADCK4 mutations who have been diagnosed in the asymptomatic period: effects of early initiation of CoQ10 supplementation.Semantic proximity Read ↗

ADCK4 deficiency destabilizes the coenzyme Q complex, which is rescued by 2,4-dihydroxybenzoic acid treatmentSemantic proximity Read ↗

Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment.Semantic proximity Read ↗

Focal segmental glomerulosclerosis and medullary nephrocalcinosis in children with ADCK4 mutations.Semantic proximity Read ↗

ADCK4-Associated Glomerulopathy Causes Adolescence-Onset FSGS.Semantic proximity Read ↗

ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption.Semantic proximity Read ↗

Oral Coenzyme Q10 supplementation leads to better preservation of kidney function in steroid-resistant nephrotic syndrome due to primary Coenzyme Q10 deficiency.Semantic proximity Read ↗

[Diagnosis and treatment of primary coenzyme Q10 deficiency associated glomerulopathy].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.